3933 CHieru
- 598
- -7-1.16%
CHieru News
CHieru: Interim report
CHieru: Financial Report - Term 27 (2023/04/01 - 2024/03/31)
CHieru: Confirmation letter
CHieru: Financial statement explanation materials for the March 2024 period.
Stocks that moved the previous day include Ridge-i, Pharmafoods, and Tokyo Seimitsu, among others.
Stock name <code>11-day closing price ⇒ Previous day comparison Chiel <3933> 558+172 Announcement of increase in dividend estimate for fiscal year ending March 2025. Nitto Uny <3524> 1618 +1382 Despite downward revisions in operating profit estimates for the fiscal year ending April 2014, revenue, ordinary profit, and net profit estimates have been upward revised. B & P <7804> 1647-127 The growth rate has shrunk from 2.8 times the first quarter to a 15.9% increase in operating profit for the first half. VEGA <3542> 677-265 Sales in the month decreased by 17.7%. Nippon Information C.
Active and newly established stocks in the afternoon session.
*Chiel <3933> announced its dividend increase forecast for the fiscal year ending March 1725. * Nittan Mesh <3524> expects to lower its operating profit for the fiscal year ending April 13824, but raise its revenue, ordinary income, and net profit outlook. * B and P <7804> The growth rate has decreased from 2.8 times the first quarter's growth to a 15.9% increase in operating profit for the first half. * VEGA <3542> Sales in May decreased by 17.7%. * Japan Information <4054> +607
Investment Strategy for June 11th [today].
[FISCO selected stocks] [Material stocks] Pharmafoods <2929> 862 yen (6/10) Mainly engaged in supplement and cosmetic e-commerce. Also handles functional materials. Announced third quarter results. Cumulative operating profit was 3.266 billion yen (a 99.9% increase over the same period last year). Profit increased from 1.535 billion yen in the first half. At the same time, it strengthened advertising and publicity for new products while optimizing overall advertising and publicity expenses. Operating profit for the July 2024 period is expected to be 2.7 billion yen (a 25.2% decrease from the previous period) until the third quarter.
Pay attention to Kurazushi and PharmaF, while B Garage and Altona may be sluggish.
On the 10th of yesterday's U.S. stock market, the Dow Jones Industrial Average was up 69.05 dollars to 38,868.04, the Nasdaq Composite Index was up 59.40 points to 17,192.53, and the Chicago Nikkei 225 Futures were up 185 yen from the Osaka-Nichu ratio to 39,185 yen. The exchange rate is 1 dollar = 157.00-10 yen. In today's Tokyo market, Pharma F <2929> with a cumulative operating profit increase of 99.9% for the third quarter, Kura Sushi <2695> which upwardly revised its performance forecast for the fiscal year 2024 ending in October, and revenue and operating profit
Kura Sushi upwardly revised its operating profit to 5.5 billion yen from 2.4 billion yen on October 24th.
Kura Sushi <2695> announced a revision of its financial estimates for the fiscal year ending October 2024. The revenue has been revised upwards from 226.2 billion yen to 234.0 billion yen and the operating profit has been revised upwards from 2.4 billion yen to 5.5 billion yen, exceeding the consensus upper limit level (about 5.1 billion yen). Despite the difficult situation of rising procurement prices, labor and utility costs in domestic business, the company's strength in fair trade centered on high-quality products such as maguro and kani, and the popular character Chiikawa and theatrical versions.
Check disclosure information for "Tomorrow's Good and Bad Materials"! (Announcement on June 10th).
【Good Materials】- - - - - - - - - - - - ■Trial Holdings [TSE G] Same-store sales in May increased by 5.2% compared to the same month last year, continuing the trend of revenue growth. ■Tamahome [TSE P] May order intake exceeded the previous year's performance for the first time in 5 months, increasing by 13% compared to the same month last year. ■Green Energy & Company [TSE G] This year's ordinary profit is expected to increase by 12%, and dividends are expected to increase by 1 yen. ■Morozoff [TSE P] 2-
CHieru: Announcement regarding the revision of dividend financial estimates for the March 2025 period (28th term) and abolition of shareholder privilege system.
CHieru: Announcement regarding the acquisition (subsidiarization) of Trust Communication Co., Ltd. shares and the revision of the full-year financial estimates.
CHIeru Issues FY Dividend Plan to Y10.00
CHIeru Issues FY Dividend Plan to Y10.00
CHIeru Keeps FY Net View at Y400.00M
GROUP New Forecast Prior For Year To Mar 2025 Forecast Revenue Y5.00 bln Y4.80 bln Operating Profit Y600.00 mln
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/20)
[Good material] ---- ---- ■ Taisei Onkyo [Tokyo Stock Exchange S] will carry out stock buybacks up to 250,000 shares (1,125 million yen in value), which is 3.88% of the number of issued shares (excluding company shares). The purchase period is from 5/21 to 5/29. ■Gokurakuyu Holdings [Tokyo Stock Exchange S] Earnings for the first fiscal year ended 3.9 times higher. Earnings for the fiscal year ending January-March (4Q) increased 30%, and financial results for the current fiscal year were not disclosed. ■Amiyaki [East
CHIERU: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
CHIeru FY Net Y349.00M Vs Net Y423.00M
CHIeru FY Net Y349.00M Vs Net Y423.00M
Open H, Mitsui Chemicals, Mitsubishi Chemical G, WOWOW (15 days) (1380-4990)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/15 (Wed) ＜1380＞Akigawa Pasture ＜1446＞Candyle＜1447＞itbookHD ＜145A＞ELISBE＜148A＞Hatch Work ＜149A＞Shinka ＜150A＞JSH ＜1514＞Residence
CHIeru Cuts FY Net View to Y320.00M
GROUP New Forecast Prior For Year To Mar 2024 Forecast Revenue Y4.50 bln Y4.50 bln Operating Profit Y650.00 mln
CHIeru Raises FY Dividend Plan to Y7.00
CHIeru Co. Ltd. (3933.TO) PARENT Latest Revision Previous For Year to Mar 2024 Plan Year-end Y7.00 Y5.00 Annual Y7.00 Y5.0
Analysis
Price Target
No Data
